跳至主要内容
临床试验/NCT06921291
NCT06921291已完成1 期

Role of Salbutamol in the Management of Transient Tachypnea of the New Born

Khyber Teaching Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Salbutamol nebulization improved transient tachypnea of the new born compared to normal saline nebulization alone.

研究概览

简要总结

Role of Salbutamol in the management of transient tachypnea of the new born

详细描述

Role of Salbutamol in the management of transient tachypnea of the new born Abstract:

Background Transient tachypnea of the newborn (TTN) is a common respiratory disorder in the early neonatal period due to delayed clearance of fetal lung fluid. Salbutamol, a β2-adrenergic agonist, may enhance lung fluid clearance through stimulation of epithelial sodium channels and Na-K-ATPase. However, the therapeutic role of Salbutamol in TTN management remains controversial with limited clinical evidence, necessitating further investigation.

Objective:

To compare the mean change in transient tachypnea of newborn score with inhaled salbutamol and normal saline.

Study Design:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Day 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Neonates with transient tachypnea

排除标准

  • age above 28 days
  • Other diseases than transient tachypnea of the new born

研究组 & 干预措施

Role of Salbutamol in the management of transient tachypnea of the new born

Experimental

Salbutamol treatment compared to normal saline in patients with transient tachypnea of the new born

干预措施: Salbutamol (Ventolin®) (Drug)

结局指标

主要结局

Salbutamol nebulization improved transient tachypnea of the new born compared to normal saline nebulization alone.

时间窗: 4 months

Two study groups ,one using Salbutamol nebulization and other using normal saline nebulization . The one group with Salbutamol nebulization improved a lot than the group using normal saline nebulization. The study was conducted in Khyber Teaching Hospital Peshawar neonatal unit .

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hayat Ullah

Doctor, pediatrics specialist

Khyber Teaching Hospital

研究点 (1)

Loading locations...

相似试验

Role of Salbutamol in the Management of Transient... | 临床试验